As early as 2011, researchers applied immunohistochemistry to analyze the expression of ribosomal protein L36 (RPL36) in 60 specimens from HCC patients and assessed the prognostic value of RPL36 through univariate and multivariate analysis of patient survival. The gene discussed is RPL36; the disease is hepatocellular carcinoma.